Financial News

Merck To Acquire Pandion Therapeutics For $60 Per Share In Cash

Merck and Pandion Therapeutics announced that the companies have entered into a definitive agreement, under which Merck, through a subsidiary, will acquire Pandion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback